Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues SCNX Q1 2026 Earnings Narrowerthanexpected loss drives positive surprise despite revenue absence POCI Q1 2026 Earnings Narrow Loss Amid Quiet Quarter Revenue Data Not Disclosed OPENLANE Q1 2026 Earnings EPS Beats Estimates by 124 Stock Retreats Slightly FNB Q1 2026 Earnings EPS Misses Estimates Slightly Stock Edges Higher BiomX Inc PHGE Q4 2025 Earnings Deep EPS Miss Overshadowed by 98 Stock Surge